wersja polska  
Mediton - Publishing House
Start page  Journals  Books  Conferences  News  Mediton  Contact   
print this
   Allergy Asthma Immunology - archive  

Allergy Asthma Immunology
     Editorial staff
     Editorial board
     For authors
Allergology Review

 Search in articles:
  Authority of Polish Society of Allergology

vol 6. no 4. December 2001  

Efficacy and safety of a new H1 receptor blocker - fexofenadine in the treatment of allergic diseases
Maria Wrzyszcz, Andrzej M. Fal, Radosław Hora

A review of current literature on efficacy and safety of fexofenadine, a new antihistaminic drug, in the treatment of selected allergic diseases is presented. Analysis of several clinical trials suggests that the new drug has a high action potency with relatively few side effects when compared to its precursor - terfenadine.
Alergia Astma Immunologia, 2001, 6(4), 191-193

keywords: sezonowy alergiczny nieżyt nosa, alergiczne zapalenie spojówek, przewlekła pokrzywka idiopatyczna, feksofenadyna, aktywny metabolit terfenadyny, seasonal allergic rhinitis, allergic conjunctivitis, chronic idiopathic urticaria, fexofenadine

pages: from 191 to 193

estimated time of download (60 kB)
broadband speed:561282565121024[kbps]

You need to have Adobe Acrobat Reader to view the PDF file. It's free. If you don't have the Adobe Acrobat Reader plugin yet, you can get it HERE.

Start page | Journals | Books | Conferences | News | Mediton | Contact

Copyright © 1996-2020 Mediton Publishing House | All rights reserved.